Findings from the master regulator analyses affirm previously reported relationships between neuropsychiatric disorders and mutations of TCF4 that have been implicated not only in depression, but also in schizophrenia and autism (Amare et al., 2019; Li et al., 2019). This evidence concerns the gene TCF4 and depressive symptom measurement.